1. Repository of OAI
Ελληνικά   English  

Browsing by Author Samantas, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 20 to 39 of 59 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology GroupNicolaides, C.; Dimopoulos, M. A.; Samantas, E.; Bafaloukos, D.; Kalofonos, C.; Fountzilas, G.; Razi, E.; Kosmidis, P.; Pavlidis, N.24-Nov-2015-
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trialPentheroudakis, G.; Kalogeras, K. T.; Wirtz, R. M.; Grimani, I.; Zografos, G.; Gogas, H.; Stropp, U.; Pectasides, D.; Skarlos, D.; Hennig, G.; Samantas, E.; Bafaloukos, D.; Papakostas, P.; Kalofonos, H. P.; Pavlidis, N.; Fountzilas, G.24-Nov-2015-
Induction chemotherapy with cisplatin, epirubicin, and paclitaxel (CEP), followed by concomitant radiotherapy and weekly paclitaxel for the management of locally advanced nasopharyngeal carcinoma - A Hellenic Cooperative Oncology Group Phase II StudyFountzilas, G.; Tolis, C.; Kalogera-Fountzila, A.; Karanikiotis, C.; Bai, M.; Misailidou, D.; Samantas, E.; Athanassiou, E.; Papamichael, D.; Tsekeris, P.; Catodritis, N.; Nicolaou, A.; Plataniotis, G.; Makatsoris, T.; Papakostas, P.; Zamboglou, N.; Daniilidis, J.24-Nov-2015-
Intensified carboplatin regimen with GM-CSF support in non-small cell lung cancer (NSCLC). A Hellenic Co-operative Oncology Group Study (HeCOG)Nicolaides, C.; Klouvas, G.; Fountzilas, G.; Athanassiadis, A.; Skarlos, D.; Samantas, E.; Kosmidis, P.; Mylonakis, N.; Pavlidis, N.24-Nov-2015-
Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 womenPentheroudakis, G.; Fountzilas, G.; Bafaloukos, D.; Koutsoukou, V.; Pectasides, D.; Skarlos, D.; Samantas, E.; Kalofonos, H. P.; Gogas, H.; Pavlidis, N.24-Nov-2015-
Metronomic Oral Vinorelbine in Patients with Recurrent Breast, Prostate or Non-Small Cell Lung Cancer: Optimal Dose-Finding Trial of the Hellenic Cooperative Oncology GroupBriasoulis, E.; Kalofonos, H.; Samantas, E.; Varthalitis, I.; Syrigos, K. N.; Fountzilas, G.; Pappas, P.; Sainis, I.; Puozzo, C.; Pavlidis, N.24-Nov-2015-
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group studyBriasoulis, E.; Fountzilas, G.; Bamias, A.; Dimopoulos, M. A.; Xiros, N.; Aravantinos, G.; Samantas, E.; Kalofonos, H.; Makatsoris, T.; Mylonakis, N.; Papakostas, P.; Skarlos, D.; Varthalitis, I.; Pavlidis, N.24-Nov-2015-
Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology GroupKoutras, A. K.; Fountzilas, G.; Dafni, U.; Dimopoulos, M. A.; Pectasides, D.; Klouvas, G.; Papakostas, P.; Kosmidis, P.; Samantas, E.; Gogas, H.; Briasoulis, E.; Vourli, G.; Petsas, T.; Xiros, N.; Kalofonos, H. P.24-Nov-2015-
Non small cell lung cancer in the elderly: clinico-pathologic, management and outcome characteristics in comparison to younger patientsKoumarianou, A.; Fountzilas, G.; Kosmidis, P.; Klouvas, G.; Samantas, E.; Kalofonos, C.; Pentheroudakis, G.; Economopoulos, T.; Pectasides, D.24-Nov-2015-
Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome dataMauri, D.; Pentheroudakis, G.; Bafaloukos, D.; Pectasides, D.; Samantas, E.; Efstathiou, E.; Kalofonos, H. P.; Syrigos, K.; Klouvas, G.; Papakostas, P.; Kosmidis, P.; Fountzilas, G.; Pavlidis, N.24-Nov-2015-
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG)Kosmidis, P.; Mylonakis, N.; Skarlos, D.; Samantas, E.; Dimopoulos, M.; Papadimitriou, C.; Kalophonos, C.; Pavlidis, N.; Nikolaidis, C.; Papaconstantinou, C.; Fountzilas, G.24-Nov-2015-
Paclitaxel (175 mg/m2) plus carboplatin versus paclitaxel (225 mg/m2) plus carboplatin in non-small cell lung cancer: a randomized studyKosmidis, P.; Mylonakis, N.; Fountzilas, G.; Samantas, E.; Athanassiadis, A.; Pavlidis, N.; Skarlos, D.24-Nov-2015-
Paclitaxel and carboplatin in inoperable non-small-cell lung cancer: a phase II studyKosmidis, P. A.; Mylonakis, N.; Fountzilas, G.; Samantas, E.; Athanasiadis, A.; Andreopoulou, E.; Pavlidis, N.; Skarlos, D.24-Nov-2015-
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Stathopoulos, G.; Nicolaides, C.; Kalogera-Fountzila, A.; Kalofonos, H.; Nikolaou, A.; Bacoyiannis, C.; Samantas, E.; Papadimitriou, C.; Kosmidis, P.; Daniilidis, J.; Pavlidis, N.24-Nov-2015-
Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG)Kosmidis, P. A.; Fountzilas, G.; Eleftheraki, A. G.; Kalofonos, H. P.; Pentheroudakis, G.; Skarlos, D.; Dimopoulos, M. A.; Bafaloukos, D.; Pectasides, D.; Samantas, E.; Boukovinas, J.; Lambaki, S.; Katirtzoglou, N.; Bakogiannis, C.; Syrigos, K. N.24-Nov-2015-
Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Skarlos, D.; Athanassiades, A.; Kalogera-Fountzila, A.; Samantas, E.; Bacoyiannis, C.; Nicolaou, A.; Dombros, N.; Briasoulis, E.; Dinopoulou, M.; Stathopoulos, G.; Pavlidis, N.; Kosmidis, P.; Daniilidis, J.24-Nov-2015-
Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancerFountzilas, G.; Athanassiades, A.; Kalogera-Fountzila, A.; Samantas, E.; Bacoyiannis, C.; Briassoulis, E.; Pavlidis, N.; Kosmidis, P.; Skarlos, D.24-Nov-2015-
Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck - A Hellenic cooperative oncology group phase II studyFountzilas, G.; Tolis, C.; Kalogera-Fountzila, A.; Misailidou, D.; Tsekeris, P.; Karina, M.; Nikolaou, A.; Samantas, E.; Makatsoris, T.; Athanassiou, E.; Skarlos, D.; Bamias, A.; Zamboglou, N.; Economopoulos, T.; Karanastassi, S.; Pavlidis, N.; Daniilidis, J.24-Nov-2015-
Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck: a Hellenic Cooperative Oncology Group Phase II StudyFountzilas, G.; Tolis, C.; Kalogera-Fountzila, A.; Misailidou, D.; Tsekeris, P.; Karina, M.; Nikolaou, A.; Samantas, E.; Makatsoris, T.; Athanassiou, E.; Skarlos, D.; Bamias, A.; Zamboglou, N.; Economopoulos, T.; Karanastassi, S.; Pavlidis, N.; Daniilidis, J.24-Nov-2015-
Pegfilgrastim administered on the same day with dose-dense adjuvant chemotherapy for breast cancer is associated with a higher incidence of febrile neutropenia as compared to conventional growth factor support: matched case-control study of the Hellenic Cooperative Oncology GroupSkarlos, D. V.; Timotheadou, E.; Galani, E.; Samantas, E.; Grimani, I.; Lianos, E.; Aravantinos, G.; Xanthakis, I.; Pentheroudakis, G.; Pectasides, D.; Fountzilas, G.24-Nov-2015-
Showing results 20 to 39 of 59 < previous   next >